Related Experiment Video
Updated: Aug 17, 2026
Absolute Quantitation of Inositol Pyrophosphates by Capillary Electrophoresis Electrospray Ionization Mass Spectrometry
Published on: August 13, 2021
Inositol hexaphosphate (IP6): a novel treatment for pancreatic cancer
Ponnandai Somasundar1, Dale R Riggs, Barbara J Jackson
1Louis A. Johnson VA Medical Center, Clarksburg, West Virginia; Department of Surgery, West Virginia University, Morgantown, West Virginia, USA.
Background:
Inositol hexaphosphate (IP6) is a naturally occurring polyphosphorylated carbohydrate found in food sources high in fiber content. IP6 has been reported to have significant inhibitory effects against a variety of primary tumors including breast and colon. The effects of IP6 have not been evaluated in pancreatic cancer. We hypothesized that IP6 would significantly inhibit cell growth and increase the apoptotic rate of pancreatic cancer in vitro.
Materials And Methods:
Two pancreatic cancer cell lines (MIAPACA and PANC1) were cultured using standard techniques and treated with IP6 at doses of 0.5, 1.0, and 5.0 mm. Cell viability was measured by MTT at 24 and 72 h. Apoptosis was evaluated by Annexin V-FITC and results calculated using FACS analysis. Statistical analysis was performed by ANOVA.
Results:
Significant reductions (P < 0.01) in cellular proliferation were observed with all IP6 concentrations tested in both cell lines and at both time points. Reductions in cell proliferation ranged from 37.1 to 91.5%. IP6 increased early and late apoptotic activity (P < 0.01).
Conclusions:
Treatment of pancreatic cancer with the common dietary polyphosphorylated carbohydrate IP6 significantly decreased cellular growth and increased apoptosis. Our findings suggest that IP6 has the potential to become an effective adjunct for pancreatic cancer treatment. Further in vivo and human studies are needed to evaluate safety and clinical utility of this agent in patients with pancreatic cancer.
Insights
Inositol hexaphosphate (IP6), a dietary compound, significantly inhibited pancreatic cancer cell growth and increased apoptosis in vitro. These findings suggest IP6
Area of Science:
- Oncology
- Nutritional Biochemistry
- Cell Biology
Background:
- Inositol hexaphosphate (IP6) is a natural polyphosphorylated carbohydrate found in high-fiber foods.
- IP6 demonstrates inhibitory effects on various cancers, but its impact on pancreatic cancer is unstudied.
- Pancreatic cancer remains a significant health challenge with limited treatment options.
Purpose of the Study:
- To investigate the effects of IP6 on pancreatic cancer cell growth and apoptosis in vitro.
- To determine if IP6 can inhibit proliferation and induce apoptosis in pancreatic cancer cell lines.
Main Methods:
- Two pancreatic cancer cell lines (MIAPACA and PANC1) were cultured.
- Cells were treated with varying concentrations of IP6 (0.5, 1.0, 5.0 mm).
- Cell viability (MTT assay) and apoptosis (Annexin V-FITC/FACS analysis) were measured at 24 and 72 hours.
Main Results:
- IP6 significantly reduced pancreatic cancer cell proliferation across all tested concentrations and time points (37.1-91.5% reduction).
- IP6 treatment led to a significant increase in early and late apoptotic activity in both cell lines.
- Statistical analysis confirmed the significance of these findings (P < 0.01).
Conclusions:
- Inositol hexaphosphate (IP6) effectively decreases pancreatic cancer cell growth and enhances apoptosis in vitro.
- IP6 shows potential as an adjunctive therapy for pancreatic cancer.
- Further in vivo and clinical studies are warranted to assess the safety and efficacy of IP6 in patients.
